Hit enter to search or ESC to close

Solutions
Software
Services
Customers
Resources
Company
Contact Us
Login

English 日本語简体中文

Solutions
Software
Services
Resources
Company
Contact
Login

Solutions
Software
Services
Resources
Company
Contact
Login

Home / Resources / Articles

Press Coverage

Keep up to date with the latest resources

Featured coverage

All Press Coverage

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Explore the top challenges in cell & gene therapy commercialization, featuring expert insights from Fran Brown, Ph.D., Certara.

Latest coverage

All Press Coverage

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics

Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics

All Press Coverage

Digital twins and virtual trials: A new era in rare disease drug development

Digital twins and virtual trials: A new era in rare disease drug development

The end of animal testing? Transitioning to models is promising — but no silver bullet

The end of animal testing? Transitioning to models is promising — but no silver bullet

Streamline Your Regulatory Writing with Process Infographics

Streamline Your Regulatory Writing with Process Infographics

All Press Coverage

The Medicine Maker: The Biosimulation Generation

The Medicine Maker: The Biosimulation Generation

Increasing Productivity In Pharma R&D Starts With Data

Increasing Productivity In Pharma R&D Starts With Data

How is the pharmaceutical industry addressing global health inequities?

How is the pharmaceutical industry addressing global health inequities?

Popular coverage

All Press Coverage

What’s next for Trump’s ‘most favored nation’ policy?

What’s next for Trump’s ‘most favored nation’ policy?

Rare disease drug development: challenges, support and hopes for the future

Rare disease drug development: challenges, support and hopes for the future

FDA to phase out animal testing with AI and lab-based models

FDA to phase out animal testing with AI and lab-based models

FDA plans to phase out animal testing requirements

FDA plans to phase out animal testing requirements

How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

How biosimulation and virtual trials can bust through clinical trial roadblocks

How biosimulation and virtual trials can bust through clinical trial roadblocks

All coverage

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Press Coverage Biologics Cell and Gene Therapy Certara Services Therapeutic Specialties

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

Press Coverage Certara Services Drug Development Rare and Neglected Diseases

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

Press Coverage Certara Services Drug Development

Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics

Press Coverage Biologics Certara Products - Simcyp Modeling and Simulation - QSP

Digital twins and virtual trials: A new era in rare disease drug development

Press Coverage Modeling and Simulation - QSP Rare and Neglected Diseases Therapeutic Specialties

The end of animal testing? Transitioning to models is promising — but no silver bullet

Press Coverage Certara Products - Simcyp Homepage Latest Modeling and Simulation

Streamline Your Regulatory Writing with Process Infographics

Press Coverage Certara Services

The Medicine Maker: The Biosimulation Generation

Press Coverage Certara Services Clinical Trials Drug Development Drug Safety Modeling and Simulation Modeling and Simulation - PBPK Modeling and Simulation – PK/PD Modeling and Simulation – QSP

Increasing Productivity In Pharma R&D Starts With Data

Press Coverage Certara Products - Pinnacle 21 Clinical Trials Data Standards Homepage Latest

Be the first to get the latest

Transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.

Newsletter sign up

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.

Solutions

Regulatory
Non-Animal Navigator™
Discovery
Preclinical
Early clinical
Late clinical
Market access and commercial
Strategic Leadership

Contact

Sales inquiry
Technical support hub

x-twitter
facebook
linkedin
youtube

Press Coverage

Featured coverage

Latest coverage

Popular coverage

All coverage

Newsletter sign up

Quick links

Solutions

Contact